David Crosby

British and American scientists joined the search for the earliest signs of cancer in a test for the detection and treatment of the disease, before it.

are you going to "give birth" to see cancer in the laboratory, in order to, exactly what it looks like "the first day".

It is one of the research is focus of new International Alliance for cancer early detection.

together, the early detection of cancer Work, my patients will benefit from faster reads.

Cancer Research UK has together with the universities of Cambridge, Manchester, University College London and Stanford and Oregon in the United States, to ideas, technologies and know-how in this area.

Together, The Scientists are developing the target, the less invasive tests, such as blood, breath and urine tests, for monitoring of high-risk patients, the improvement of imaging techniques for the early detection of cancer and search for a virtually undetectable signs of the disease.

But they say it is "like looking for a needle in a haystack" and 30 years.

"The fundamental problem is that we never get cancer born on a people," says Dr. David Crosby , head of early detection research at Cancer Research UK.

"By the time it's found, it has already been established. "

researchers from Manchester looked for by scientists, for example, grows in the human breast tissue in the laboratory with synthetic cells of the immune system, to see if you can lead, the very early, subtle changes that could lead to cancer.

Prof Rob Bristow said it was like a "living tissue bank, outside the patient".

However, there is the risk of over-diagnosis, because not all of the early cellular changes turn into cancer is always.

So, the cancer researchers say, you need to be very precise, also the genes that people are born with and The Environment in which they Grow Up , to find out an individual's unique personal risk of different types of cancer.

Only then you will know when to intervene.

To date, scientists say research for the early detection was small-scale and disconnected, lacking The Power of studies, large populations of people.

Dr. Crosby said the collaboration will "induce a sea-change in our health systems, move him out of expensive fire-fighting of late-stage disease, to intervene in the situation, in its earliest point and deliver fast, cost-effective treatment".

the Figures show that 98% of breast cancer patients live five years or more, if the disease is diagnosed at stage 1 - the earliest possible time, compared to only 26% in stage 4, The Most advanced stage.

But currently only around 44% of the patients with breast cancer are diagnosed in the earliest stage.

In the UK, screening programmes exist for breast, bowel and cervical cancer, when people reach a certain age.

But, there is currently no reliable screening tools for other types of cancer, such as pancreatic, liver, lung, and prostate cancer, which means that the survival rates are often much lower.

Professor Mark Emberton, of UCL, said the growth of the imaging, such as MRI, needles was a "quiet revolution" that could replace, used in biopsies in The Diagnosis of prostate cancer.

"Imaging only sees the aggressive cells, it overlooks the things you do not want to be found and addresses to over-diagnosis," he said, but he warned that it was expensive and took time, and was "not ready for Prime Time yet".

more hyper-polarized MRI scans and photo-acoustics, where the laser light is delivered to the Tumor, creating sound waves which are analysed to pictures to generate, the next progress is tested in the imaging.

Prof Emberton said the next goal was to see which types of cancer lent themselves to this type of imaging.

At the University of Cambridge, Prof Rebecca Fitzgerald is the development of an advanced endoscope to detect pre-cancerous lesions in the food pipe and colon.

She Said early detection is still not the attention it deserves, and some of the tests for cancer can be very easy and inexpensive.

Prof Fitzgerald said she is looking forward to the cooperation with international colleagues to take the ideas "all the way from the laboratory bench to the bedside".

Cancer Research UK investment of £40m in The International Alliance for cancer screening in the next five years, with $20m Canary Center at Stanford University and the OHSU-knight-cancer-carries-Institute in Oregon .

Source of news: bbc.com